Results 51 to 60 of about 43,659 (238)
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri +20 more
wiley +1 more source
Differential diagnoses of nocturnal fear and movement paroxysm: a case report [PDF]
Recurrent nocturnal behavioural and movement paroxysms are a diagnostic challenge for the clinical pediatrician. We report on an adolescent girl who presents recurrent stereotypical nightmare-like episodes occurring during non-REM sleep stages 1-2 (N1 ...
Datta, Alexandre +2 more
core
Two Independent Predictors of Nightmares in Posttraumatic Stress Disorder [PDF]
Understanding nightmares (NM) and disturbing dreams (DD) in posttraumatic stress disorder (PTSD) has been limited by the unpredictability of these events and their nonappearance in the sleep laboratory. This study used intensive, longitudinal, ambulatory methods to predict morning reports of NM/DD in veterans in whom chronic, severe PTSD was diagnosed ...
Katherine E, Miller +3 more
openaire +2 more sources
0806 Prescription Correlates of Nightmare Disorder Among Veterans [PDF]
Abstract Introduction In the James A. Haley Veterans Administration (JAHVA) Vista database, the ICD-9 code 307.47 for Nightmare disorder (ND) is infrequently used and appears independently of codes for PTSD. We wanted to determine if certain drugs that may affect sleep are associated with ND.
W Anderson +7 more
openaire +1 more source
Background Up to 71% of trauma victims diagnosed with PTSD have frequent nightmares (NM), compared to only 2% to 5% of the general population. Objectives The present study examined whether nightmares before
Levrier +4 more
doaj +1 more source
Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson’s Disease
Recently, zonisamide (ZNS) has been approved as a new adjunctive therapy for motor complications of Parkinson’s disease (PD). More recently, ZNS was reported to be effective for the management of impulse control behavior in PD, suggesting potential ...
Hiroshi Kataoka, Satoshi Ueno
doaj +1 more source
Background Primary orthostatic tremor (POT) is a rare hyperkinetic movement disorder with limited and largely ineffective treatment options. Perampanel has been suggested as a therapy, but has so far only been investigated in small studies with short duration.
Wietske A. Babeliowsky +4 more
wiley +1 more source
Individuals with Eating Disorder Symptoms Have an Increased Risk of Nightmares
Objective: This preliminary study was aimed to examine if individuals with eating disorder symptoms have a higher incidence of nightmares. Additionally, the possible influence of general psychological distress on the relationship between eating disorder ...
William E. Kelly, Qiujun Yu
doaj +1 more source
ABSTRACT Adverse childhood experiences (ACEs) are often positively associated with mental health conditions. We examined whether emotional support attenuates the association between ACE clusters and both social problem solving and mental health assessments (depression, anxiety, post‐traumatic stress disorder (PTSD) symptoms).
Laura Mata Lopez +4 more
wiley +1 more source
Background Sleep disturbances are often referred to as a hallmark and as core symptoms of post-traumatic stress disorder (PTSD). Untreated sleep disturbances can contribute to the maintenance and exacerbation of PTSD symptoms, which may diminish ...
Hinuga Sandahl +4 more
doaj +1 more source

